Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

As if battling cancer wasn't difficult enough, many patients lose their hair — especially if they are undergoing chemotherapy ...

A targeted therapy called sevabertinib has been approved for patients with non-small cell lung cancer that carries an ...

A new study links ultra-processed foods after cancer diagnosis to lower survival. Learn why diet matters during recovery and ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

Researchers at Case Western Reserve University have discovered a way to breach one of cancer's most stubborn defenses: the ...